LAKE FOREST, Calif., July 16, 2014 (GLOBE NEWSWIRE) -- Tenex Health, Inc. today proudly announced it has reached two significant milestones in offering patient relief for Chronic Tendon Disease. Over 500 specialists from across the United States now offer the Tenex Health TX™ System to patients who have been suffering from chronic tendon pain. These specialists have performed over 15,000 procedures since the introduction of the TX System in early 2012, offering patients a minimally invasive, rapid recovery, solution. The accelerated adoption of Tenex Health TX reflects the increased acceptance of the procedure by both physicians and patients.
Over 10 Million people visit their doctor each year for tendon pain, and many of these patients become chronic sufferers. Commonly called Tennis Elbow, Golfer's Elbow, Runner's Knee, Achilles Tendonitis and Plantar Fasciitis, the pain can be disabling, causing the individual to limit the activities of everyday life. Patients can suffer for months to years with current conservative treatments, and more invasive procedures require a higher level of risk and long recovery periods. Tenex Health TX is rapidly becoming the procedure of choice for skilled physicians and people who have had disabling tendon pain for at least three months.
"We are pleased that so many physicians are recognizing the unique attributes of the Tenex Health TX System and are rapidly adopting the TX technology, offering their patients an opportunity to get back to pain-free living as quickly as possible," said Jay Hallinan, CEO of Tenex Health. "The rapid adoption rate by physicians and patients is demonstrating the high need for a minimally invasive solution. We continue to believe the Tenex Health TX procedure will become the standard of care for those patients suffering from the debilitating pain of damaged tendons."
About Tenex Health, Inc.
Tenex Health, Inc. (www.tenexhealth.com) (www.tenexhealthpatient.com), develops and markets innovative therapies for the treatment of joint pain in tendon or plantar fascia tissue caused by Chronic Tendon Disease. The company's minimally invasive technology is designed to specifically cut and remove the damaged tissue in a targeted manner with the use of ultrasound image guidance. The entire procedure is completed in an outpatient setting within 20 minutes using only a local anesthetic. The precision of removing only the damaged tissue allows patients to enjoy quick recovery times without additional treatments or physical therapy.